Stryker Corporation $SYK Position Raised by Tobam

Tobam grew its position in shares of Stryker Corporation (NYSE:SYK) by 4,504.0% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 2,302 shares of the medical technology company’s stock after acquiring an additional 2,252 shares during the quarter. Tobam’s holdings in Stryker were worth $809,000 as of its most recent filing with the SEC.

Other institutional investors have also modified their holdings of the company. Brighton Jones LLC increased its stake in shares of Stryker by 15.4% in the fourth quarter. Brighton Jones LLC now owns 4,564 shares of the medical technology company’s stock valued at $1,643,000 after purchasing an additional 609 shares during the period. Schnieders Capital Management LLC. acquired a new position in shares of Stryker during the second quarter worth approximately $205,000. Marshall Wace LLP boosted its position in shares of Stryker by 107.9% during the second quarter. Marshall Wace LLP now owns 5,700 shares of the medical technology company’s stock worth $2,255,000 after buying an additional 77,831 shares during the period. Nebula Research & Development LLC bought a new position in Stryker in the 2nd quarter worth approximately $219,000. Finally, HUB Investment Partners LLC acquired a new stake in Stryker in the 2nd quarter valued at approximately $253,000. Institutional investors own 77.09% of the company’s stock.

Insider Buying and Selling at Stryker

In other news, VP Robert S. Fletcher sold 4,544 shares of the firm’s stock in a transaction dated Thursday, May 28th. The shares were sold at an average price of $306.87, for a total transaction of $1,394,417.28. Following the completion of the transaction, the vice president owned 10,582 shares in the company, valued at approximately $3,247,298.34. This trade represents a 30.04% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Ronda E. Stryker sold 310,000 shares of Stryker stock in a transaction that occurred on Tuesday, May 26th. The stock was sold at an average price of $312.23, for a total transaction of $96,791,300.00. Following the completion of the transaction, the director directly owned 1,924,880 shares in the company, valued at $601,005,282.40. This represents a 13.87% decrease in their position. The SEC filing for this sale provides additional information. In the last three months, insiders sold 323,264 shares of company stock valued at $100,659,489. 4.60% of the stock is owned by insiders.

Wall Street Analyst Weigh In

A number of research analysts have issued reports on the company. Sanford C. Bernstein set a $410.00 price target on Stryker in a research report on Friday, May 1st. Leerink Partners lowered their price target on Stryker from $410.00 to $407.00 and set an “outperform” rating on the stock in a report on Friday, June 5th. JPMorgan Chase & Co. cut their price objective on shares of Stryker from $445.00 to $400.00 and set an “overweight” rating on the stock in a research note on Friday, May 1st. Robert W. Baird set a $385.00 price objective on shares of Stryker in a report on Friday, May 1st. Finally, Needham & Company LLC decreased their target price on shares of Stryker from $454.00 to $418.00 and set a “buy” rating for the company in a research report on Friday, May 1st. Sixteen equities research analysts have rated the stock with a Buy rating and six have given a Hold rating to the company’s stock. According to data from MarketBeat.com, Stryker has a consensus rating of “Moderate Buy” and a consensus target price of $395.33.

Stryker Stock Performance

Shares of NYSE SYK opened at $308.62 on Friday. Stryker Corporation has a 1 year low of $281.00 and a 1 year high of $404.87. The firm has a market cap of $118.31 billion, a P/E ratio of 35.72, a PEG ratio of 1.97 and a beta of 0.78. The stock has a fifty day moving average price of $313.81 and a two-hundred day moving average price of $341.71. The company has a debt-to-equity ratio of 0.62, a quick ratio of 1.25 and a current ratio of 2.11.

Stryker (NYSE:SYK) last announced its quarterly earnings data on Thursday, April 30th. The medical technology company reported $2.60 earnings per share for the quarter, missing the consensus estimate of $2.98 by ($0.38). Stryker had a net margin of 13.20% and a return on equity of 23.42%. The firm had revenue of $6.02 billion during the quarter, compared to analyst estimates of $6.34 billion. During the same quarter last year, the company earned $2.84 EPS. The company’s quarterly revenue was up 2.6% compared to the same quarter last year. Stryker has set its FY 2026 guidance at 14.900-15.100 EPS. Research analysts forecast that Stryker Corporation will post 14.98 EPS for the current fiscal year.

Stryker Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, July 31st. Shareholders of record on Tuesday, June 30th will be issued a $0.88 dividend. This represents a $3.52 dividend on an annualized basis and a yield of 1.1%. The ex-dividend date of this dividend is Tuesday, June 30th. Stryker’s dividend payout ratio is presently 40.74%.

Stryker Profile

Stryker Corporation is a global medical technology company that designs, manufactures and markets a broad range of products and services for use in hospitals, surgeons’ offices and other healthcare facilities. Its primary business activities span orthopedics (including joint replacement implants, trauma and extremities products), surgical equipment and operating room technologies (such as visualization, navigation and powered instruments), neurotechnology and spine solutions, and patient-handling and emergency medical equipment.